What New Catalysts Are Rewriting the Narrative for Wave Life Sciences? [Yahoo! Finance]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Yahoo! Finance
6.63% and revenue growth expectations ease from around 16.81% to approximately 14.37%. Backers point to de risked editing approaches in alpha 1 antitrypsin deficiency, growing validation of GalNAc delivery, and early but promising obesity data as reasons for higher long term confidence and a richer price target, despite slightly more conservative growth assumptions. Stay tuned to see how you can track these evolving drivers and keep ahead of future shifts in the Wave Life Sciences narrative. Stay updated as the Fair Value for Wave Life Sciences shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Wave Life Sciences. ?? Bullish Takeaways Jefferies highlights that Korro Bio's AATD setback has "clearly validated" Wave Life Sciences' editing approach in alpha 1 antitrypsin deficiency and strengthened its competitive position, supporting a Buy rating and a $26 price target that underpins the higher fair value narrat
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- WAVE Life Sciences (NASDAQ:WVE) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- WAVE Life Sciences (NASDAQ:WVE) was given a new $32.00 price target on by analysts at UBS Group AG.MarketBeat
- WAVE Life Sciences (NASDAQ:WVE) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..MarketBeat
- WAVE Life Sciences (NASDAQ:WVE) was given a new $50.00 price target on by analysts at Truist Financial Corporation.MarketBeat
- Wave Life (WVE) Shares Nearly Triple on Encouraging Obesity Drug Trial [Yahoo! Finance]Yahoo! Finance
WVE
Earnings
- 11/10/25 - Miss
WVE
Sec Filings
- 12/15/25 - Form SCHEDULE
- 12/15/25 - Form 4
- 12/11/25 - Form 424B5
- WVE's page on the SEC website